A Phase 1 Study of XH-S003 in Healthy Volunteers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a phase 1, randomised, first-in-human, double-blinded, placebo-controlled, SAD (Single Ascending Dose) and MAD (Multiple Ascending Dose) study to assess the PK, safety, and tolerability of XH-S003 in healthy volunteers. In addition, this study evaluates the effects of food on XH-S003 under a two-period, cross-over study setting.
Epistemonikos ID: 5d48841c908200e1f8d994be0ab336bb75dfb20a
First added on: May 15, 2024